Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
    -0.15p
  • 52 Week High: 14.13
  • 52 Week Low: 3.23
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 607,805
  • Market Cap: £4.37m
  • RiskGrade: 435

Deal with Barclays    Trade now with Barclays Stockbrokers

Geographical - by origin

  31-Dec-1031-Dec-09
Revenue
Europe0.18100%0.01100%
Total 0.18100% 0.01100% 
 
Profit Before Tax
Europe(0.09)n/a(0.35)22%
UK0.19n/a(1.26)78%
Unanalysed0.15n/a0.34n/a
Total 0.25n/a (1.26)100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  31-Dec-1031-Dec-09
Revenue
Drug development0.1376%n/an/a
Self-test diagnostic kits0.0424%0.01100%
Total 0.18100% 0.01100% 
 
Profit Before Tax
Drug development0.22n/a(1.54)96%
Self-test diagnostic kits(0.12)n/a(0.06)4%
Unanalysed0.15n/a0.34n/a
Total 0.25n/a (1.26)100% 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page